SCHEMBL20848342

SCHEMBL20848342

CC1(C(=O)Oc2ccc(-c3ccc(OC(=O)C4(C)COC(=O)OC4)cc3)cc2)COC(=O)OC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HSD17B10 Q99714 2/20 0.37
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 2/20 0.34
MAPT P10636 1/20 0.34
XBP1 P17861 1/20 0.34
LMNA P02545 4/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
TP53 P04637 2/20 0.34
PTGS2 P35354 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
NPSR1 Q6W5P4 2/20 0.33
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20848344 0.95 POLB (0.40) POLBL3MBTL1HSD17B10KMT2AMEN1
SCHEMBL17589271 0.87 L3MBTL1 (0.50) POLBL3MBTL1HSD17B10KMT2AMEN1
SCHEMBL20848640 0.85 MAPT (0.38) POLBL3MBTL1KMT2AMEN1TDP1
SCHEMBL23747260 0.78 KMT2A (0.46) POLBL3MBTL1HSD17B10KMT2AMEN1
SCHEMBL832774 0.73
SCHEMBL663921 0.73 MEN1 (0.33) POLBHSD17B10KMT2AMEN1RAB9A
SCHEMBL18257757 0.73 LIPE (0.36) KMT2AMEN1GAAMAPTKDM4E
SCHEMBL17688059 0.72 ATM (0.31) ATM
SCHEMBL20848347 0.71 CYP3A4 (0.39) POLBKMT2AMEN1ALDH1A1
SCHEMBL17301086 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190091338-A1 MIKTO-ARM STAR POLYMERS FOR DELIVERY OF THERAPEUTIC AGENTS INTERNATIONAL BUSINESS MACHINES CORPORATION 2019-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190091338-A1 MIKTO-ARM STAR POLYMERS FOR DELIVERY OF THERAPEUTIC AGENTS COQ8A, COQ8B, STARD7 POLB 485/4885L3MBTL1 986/4885HSD17B10 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.